Skip to main content
. 2018 Apr 24;10:93. doi: 10.3389/fnagi.2018.00093

Figure 3.

Figure 3

Chronic CsA treatment reduces cognitive impairments. (A) Experimental timeline. PB, puzzle box; OF, Open Field; YM, Y-Maze. (B) Stroke-Alone (n = 18), but not Stroke+CsA (n = 16), showed persisting cognitive deficits compared to controls (n = 14) in the PB task; *p < 0.05. (C) Stroke+CsA animals show significant improvement at day 22–24 (#) and 45–47 (*) compared to day 4–6. (D) Stroke-alone animals show spontaneous recovery in trial 9 at long-term time points. (E) No significant differences were observed in the amount of time spent in the corner zones of the maze between Stroke-alone (n = 11), Stroke+CsA (n = 11), and control (n = 8) groups. Day 22–24: *p < 0.05, **p < 0.01, ****p < 0.0001; Day 45–47: #p < 0.05, ##p < 0.01, ###p < 0.001.